Skip to main content

Table 4 Logistic regression model exploring association between baseline anti-CCP titer and radiographic and functional outcome at 5 years

From: Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis

5-year outcome

OR (95% CI)

P

Adjusted ORa

Adjusted Pa

Erosions

1.03 (1.02, 1.04)

< 0.0001

1.03 (1.01, 1.03)

< 0.0001

Larsen score > 15

1.03 (1.02, 1.03)

< 0.0001

1.02 (1.01, 1.03)

< 0.0001

HAQ ≥ 1

1.01 (1.01, 1.02)

< 0.0001

1.00 (0.99, 1.01)

0.47

  1. aAdjusted for age, gender, symptom duration and CRP, RF, HAQ, and swollen- and tender-joint counts at baseline. OR, odds ratio; CI, confidence interval. Baseline anti-CCP titer was available in 596 patients. ACR, American College of Rheumatology criteria for rheumatoid arthritis; DAS, disease activity score; HAQ, Health Assessment Questionnaire.